Day: May 16, 2022
-
Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease
WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming…
Read More » -
Zenas BioPharma soumet une demande en Chine pour un nouveau médicament expérimental pour ZB001 portant sur le traitement de l’ophtalmopathie thyroïdienne
WALTHAM, Massachusetts et SHANGHAI, Chine, 16 mai 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, une société biopharmaceutique mondiale déterminée à devenir…
Read More » -
Zenas BioPharma solicita aprovação do medicamento investigacional ZB001 na China para o tratamento de Doença Ocular da Tireoide
WALTHAM, Mass. e XANGAI, China, May 15, 2022 (GLOBE NEWSWIRE) — A Zenas BioPharma, uma empresa biofarmacêutica global comprometida em…
Read More »